Diallyl trisulfide and diallyl disulfide ameliorate cardiac dysfunction by suppressing apoptotic and enhancing

Yao-Te Huang1, Chun-Hsu Yao, Chia-Li Way

  • 1Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.

Insights

Garlic compounds diallyl trisulfide (DATS) and diallyl disulfide (DADS) show therapeutic potential for diabetic cardiomyopathy. These compounds, found in garlic oil, reverse cardiac dysfunction by inhibiting apoptosis and activating protective pathways.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Background:

  • Cardiovascular disease is a leading cause of death in diabetic patients.
  • Garlic and its compounds possess antioxidant and biological activities.
  • Diabetic cardiomyopathy is a serious complication of diabetes.

Purpose of the Study:

  • To investigate the effects of garlic oil (GO), diallyl disulfide (DADS), and diallyl trisulfide (DATS) on diabetic cardiomyopathy in rats.
  • To elucidate the underlying mechanisms of GO, DADS, and DATS in ameliorating cardiac dysfunction.

Main Methods:

  • Diabetic cardiomyopathy was induced in rats.
  • Cardiac function was assessed using echocardiography.
  • Apoptosis was evaluated via TUNEL and DAPI staining.
  • Protein expression and signaling pathways (PI3K-Akt) were analyzed using Western blotting.

Main Results:

  • Diabetic rats exhibited decreased cardiac function, increased oxidative stress (nitrotyrosine), elevated apoptosis (TUNEL-positive cells, caspase 3), and reduced PI3K-Akt activity.
  • GO, DADS, and DATS treatments reversed these detrimental changes.
  • Treatment increased PI3K-Akt signaling and inhibited both death receptor and mitochondria-dependent apoptotic pathways.
  • Efficacy order was DATS > DADS.

Conclusions:

  • DATS and DADS, major components of GO, demonstrate significant therapeutic potential for treating diabetic cardiomyopathy.
  • The cardioprotective effects of GO are primarily attributed to DATS and DADS.
  • These garlic compounds offer a promising therapeutic strategy by modulating apoptotic pathways and activating the PI3K-Akt signaling pathway.